Despite the many advances made in the treatment of MS over the last 2 decades, most people with MS have still been shown to transition to the more progressive phase of the disease within 15 years of diagnosis.
Concerned about the lack of almost any research about progressive stages of MS, ARMS board members met with MS researchers at the University at Buffalo’s Department of Neurology during the summer of 2013 and asked them to examine how MS affects people over 60.
In response to meeting with ARMS, they developed a unique study examining how disease progression is affected by lifestyle, various drug therapies, genes, environment, and age.
This study was designed to identify how several factors, some of which can be modified, influence MS progression over time.
Diet, and other lifestyle factors, including smoking and physical activity level, medications, genetic profile, lipid levels, as well as environmental factorssuch as exposure to specific viruses were selected to stud..
For questions about this study or its parent study, contact ARMS at [email protected].
(RESULTS OF THE STUDY WILL BE AVAILABLE BY 7/1/19 INSERT THEM HERE)
If you would like to have a voice in shaping future MS research studies like this one, we encourage you to become a member of our organization today. It's free!
To find out more, visit our membership page.
Bianca Weinstock-Guttman, MD
Professor of Neurology
State University of New York at Buffalo
Director, Jacobs MS Center for Treatment & Research
Director, Jacobs Pediatric MS Center of Excellence
Executive Director, NY State MS Consortium